« Return to News | Awards & Advancement

Dedicated Phase I Appoints New CMO

Friday, June 26, 2009 10:54 AM

Dedicated Phase I in Phoenix, Ariz., named a new chief medical officer to head its 80-bed phase I clinical research facility. Clark Springgate, M.D., Ph.D., brings more than 25 years' experience to the organization, having directed and participated in more than 256 clinical trials, including first-in-man and first-in-therapeutic-class studies.

"Having Dr. Springgate lead our clinical team furthers our commitment to bringing internationally known research physicians to Dedicated Phase I and Arizona's bioscience community," said Dedicated Phase I's founder and CEO Jason Bonanza.

In other recent personnel news from the clinical trial industry:

WuXi PharmaTech appointed Hao Zhou vice president of finance, responsible for financial planning and analysis, enterprise resource planning implementation, tax and treasury. Zhou worked for General Electric for 11 years before joining WuXi.

INC Research appointed Tom Zoda, Ph.D., as senior vice president of neuropsychiatry to the CRO's central nervous system team. Zoda will oversee all psychiatry and neurology projects on a global basis. Prior to joining INC, Zoda worked for PPD as executive director for Global Strategic Development, CNS.

West Coast Clinical Trials (WCCT) named Thomas Pillsworth, Ph.D., the new vice president of business development. Prior to joining WCCT, Pillsworth was vice president of business development at PharmaNet working in both the early- and late-stage divisions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.